J
Jeremy J. Watts
Researcher at Centre for Addiction and Mental Health
Publications - 13
Citations - 243
Jeremy J. Watts is an academic researcher from Centre for Addiction and Mental Health. The author has contributed to research in topics: Cannabis & Psychosis. The author has an hindex of 8, co-authored 12 publications receiving 147 citations. Previous affiliations of Jeremy J. Watts include University of Toronto.
Papers
More filters
Journal ArticleDOI
Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.
Shima Shakory,Shima Shakory,Jeremy J. Watts,Jeremy J. Watts,Sina Hafizi,Tania Da Silva,Tania Da Silva,Saad Khan,Saad Khan,Michael Kiang,Michael Kiang,R. Michael Bagby,Sofia Chavez,Sofia Chavez,Romina Mizrahi +14 more
TL;DR: The findings suggest that glutamate metabolites are altered in CHR, a site of key functional and structural abnormalities in schizophrenia, and associations between hippocampal glutamate metabolites and glial activation are explored.
Journal ArticleDOI
A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
Maya R. Jacobson,Maya R. Jacobson,Jeremy J. Watts,Jeremy J. Watts,Isabelle Boileau,Junchao Tong,Junchao Tong,Romina Mizrahi +7 more
TL;DR: The first review of the effects of exogenous cannabinoids on the endocannabinoid system in humans with and without psychotic disorders is conducted, finding the most well established finding is the down-regulation of cannabinoid CB1 receptors after chronic and recent cannabis exposure.
Journal ArticleDOI
In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.
Tania Da Silva,Sina Hafizi,Jeremy J. Watts,Jeremy J. Watts,Cynthia Shannon Weickert,Cynthia Shannon Weickert,Cynthia Shannon Weickert,Jeffrey H. Meyer,Sylvain Houle,Sylvain Houle,Pablo Rusjan,Pablo Rusjan,Romina Mizrahi +12 more
TL;DR: The results of this study suggest that TSPO levels in cannabis users, particularly in those with cannabis use disorder, are higher than those in non-cannabis-using controls.
Journal ArticleDOI
Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.
Huai Hsuan Tseng,Jeremy J. Watts,Jeremy J. Watts,Michael Kiang,Michael Kiang,Ivonne Suridjan,Alan A. Wilson,Alan A. Wilson,Sylvain Houle,Sylvain Houle,Pablo Rusjan,Pablo Rusjan,Romina Mizrahi +12 more
TL;DR: Elevated nigral DA responsiveness to stress is observed in antipsychotic-naïve SCZ, and this study explores how DA release in the SN and striatum might be related.
Journal ArticleDOI
Application of CRISPR genetic screens to investigate neurological diseases.
Raphaella W. L. So,Sai Wai Chung,Heather H. C. Lau,Jeremy J. Watts,Erin Gaudette,Zaid A.M. Al-Azzawi,Jossana Bishay,Lilian Tsai-Wei Lin,Julia Joung,Julia Joung,Xinzhu Wang,Gerold Schmitt-Ulms +11 more
TL;DR: This review will highlight groundbreaking studies in the CRISPR-Cas9 functional genetics field and discuss strengths and limitations of this technology for neurological disease applications and provide practical guidance on navigating the many choices that need to be made when implementing a CRISpr- Cas9 functional genetic screen for the study of neurological diseases.